509 top medical experts on Hairy Cell Leukemia across 42 countries and 25 U.S. states, including 403 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hairy Cell Leukemia: A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Leukemia (4,683), Lymphoproliferative Disorders (2,703).
  4. Clinical Trials ClinicalTrials.gov : at least 96 including 10 Active, 46 Completed, 17 Recruiting
  5. Synonyms: Leukemic Reticuloendotheliosis,  Leukemic Reticuloendotheliosis


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Grever, Michael R   Hematology   ClinicalTrials.gov Google Publications
    Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA. . Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: University of Pittsburgh School of Medicine (MD, 1971)
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Pentostatin; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Cladribine
    Categories: Therapeutic Use; Drug Therapy; Administration & Dosage; Adverse Effects; Therapy; Diagnosis

  2. Andritsos, Leslie A   Hematology   ClinicalTrials.gov Google Publications
    Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: University of Texas Medical Branch at Galveston (MD, 1999)
    Medicare Accepted
    Disclosed payments from biomedical company (BeiGene USA, Inc.) in 2021 for $20.77
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Pentostatin; Protein Kinase Inhibitors; Cladribine; Drug Eruptions
    Categories: Therapeutic Use; Drug Therapy; Adverse Effects; Administration & Dosage; Etiology; Complications

  3. Park, Jae H   Hematology & Oncology   ClinicalTrials.gov Google Publications
    Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 9 biomedical companies, totalling $21,788, including $10,980 from  Kite Pharma, Inc.
    Subjects: Leukemia, Hairy Cell; Proto-Oncogene Proteins B-raf; Antineoplastic Agents; Cladribine; Indoles; Mutation
    Categories: Therapeutic Use; Drug Therapy; Epidemiology; Genetics; Administration & Dosage; Diagnosis

  4. Saven, Alan   Hematology & Oncology  Google Publications
    Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 32 biomedical companies, totalling $44,483.46, including $14,411.59 from  Dova Pharmaceuticals
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Cladribine; Neoplasms, Second Primary; Pentostatin; Proto-Oncogene Proteins B-raf
    Categories: Therapeutic Use; Drug Therapy; Administration & Dosage; Adverse Effects; Epidemiology; Etiology

  5. Lozanski, Gerard   Anatomic Pathology & Clinical Pathology  Google Publications
    Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,218.65, including $1,218.65 from  F. Hoffmann-La Roche AG
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Pentostatin; Protein Kinase Inhibitors; Adenine; COVID-19
    Categories: Therapeutic Use; Drug Therapy; Genetics; Administration & Dosage; Analogs & Derivatives; Complications

  6. Blachly, James S   Hematology   Google Publications
    Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $7,302.5, including $4,200 from  Innate Pharma, Inc
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Protein Kinase Inhibitors; Infections; Pentostatin; Adenine
    Categories: Therapeutic Use; Drug Therapy; Adverse Effects; Complications; Diagnosis; Etiology

  7. Kraut, Eric H   Hematology   Google Publications
    Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $4,256.49, including $4,256.49 from  Global Blood Therapeutics, Inc.
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Pentostatin; Antibodies, Monoclonal, Murine-Derived; COVID-19; Cladribine
    Categories: Therapeutic Use; Drug Therapy; Complications; Pharmacology; Diagnosis; Etiology

  8. Rogers, Kerry A   Hematology  ClinicalTrials.gov Google Publications
    Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 14 biomedical companies, totalling $13,595.87, including $4,798.74 from  AbbVie Inc.
    Subjects: Leukemia, Hairy Cell; Protein Kinase Inhibitors; Adenine; Antineoplastic Agents; COVID-19; Genes, Immunoglobulin Heavy Chain
    Categories: Adverse Effects; Therapeutic Use; Complications; Drug Therapy; Etiology; Genetics

  9. Rai, Kanti R   Hematology & Oncology  Google Publications
    Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hofstra University, Hempstead, NY.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1955)
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Neoplasms, Second Primary; Proto-Oncogene Proteins B-raf; Cladribine; Indoles
    Categories: Administration & Dosage; Therapeutic Use; Drug Therapy; Epidemiology; Antagonists & Inhibitors; Diagnosis

  10. Calvo, Katherine R   Anatomic Pathology  Google Publications
    Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Subjects: Leukemia, Hairy Cell; Cladribine; Leukemia, Lymphocytic, Chronic, B-Cell; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols
    Categories: Genetics; Administration & Dosage; Pathology; Therapeutic Use; Complications; Drug Therapy

  11. Park, Christopher Y   Anatomic Pathology  Google Publications
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Top Hospital
    Physician  Clinical Trial 
    Medical school: Columbia University College of Physicians and Surgeons (MD, 2001)
    Subjects: Proto-Oncogene Proteins B-raf; Leukemia, Hairy Cell; Antineoplastic Agents; Hematopoietic Stem Cells; Indoles; Mutation
    Categories: Administration & Dosage; Genetics; Antagonists & Inhibitors; Drug Therapy; Pathology

  12. Gladstone, Douglas E   Medical Oncology  Google Publications
    Johns Hopkins University, Baltimore, MD, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: New York University School of Medicine (MD, 1992)
    Medicare Accepted
    Disclosed payments in 2021 from 6 biomedical companies, totalling $3,967.51, including $1,606.01 from  AstraZeneca Pharmaceuticals LP
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Bacterial Toxins; Exotoxins; Neoplasm Recurrence, Local; COVID-19
    Categories: Therapeutic Use; Drug Therapy; Complications; Drug Effects; Therapy

  13. Byrd, John C   Hematology  ClinicalTrials.gov Google Publications
    The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH. Top Hospital
    Physician  Guideline  Case Reports 
    Medical school: University of Arkansas College of Medicine (MD, 1991)
    Disclosed payments in 2021 from 3 biomedical companies, totalling $3,425.86, including $2,355 from  Takeda Pharmaceuticals U.S.A., Inc.
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Pentostatin; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Flavonoids
    Categories: Therapeutic Use; Drug Therapy; Diagnosis; Pharmacology; Standards; Therapy

  14. Burger, Jan A   Internal Medicine   Google Publications
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Medical school: Other (MD, 1994)
    Disclosed payments in 2021 from 3 biomedical companies, totalling $2,748.68, including $2,731.25 from  CSL Behring
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Cladribine; Receptors, Antigen, B-Cell; Antibodies, Monoclonal, Murine-Derived; CD40 Antigens
    Categories: Immunology; Therapeutic Use; Pharmacology; Administration & Dosage; Drug Therapy; Pathology

  15. Kantarjian, Hagop M   Medical Oncology  Google Publications
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Disclosed payments in 2021 from 23 biomedical companies, totalling $77,883.16, including $16,295 from  Amgen Inc.
    Subjects: Leukemia, Hairy Cell; Cladribine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; DNA Mutational Analysis
    Categories: Drug Therapy; Therapeutic Use; Administration & Dosage; Genetics; Diagnosis; Methods

  16. Zent, Clive S   Hematology   Google Publications
    James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
    Disclosed payments from biomedical company (AstraZeneca Pharmaceuticals LP) in 2021 for $68.97
    Subjects: Leukemia, Hairy Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; COVID-19; Cladribine; Cyclin D1
    Categories: Therapeutic Use; Administration & Dosage; Drug Therapy; Genetics; Pathology; Complications

  17. Wilson, Wyndham H   Medical Oncology  Google Publications
    Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Leukemia, Hairy Cell; Bacterial Toxins; Exotoxins; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine
    Categories: Therapeutic Use; Drug Therapy; Administration & Dosage; Drug Effects; Immunology; Methods

  18. Jain, Preetesh   Internal Medicine  Google Publications
    Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
    Disclosed payments in 2021 from 3 biomedical companies, totalling $6,565, including $2,400 from  Kite Pharma, Inc.
    Subjects: Leukemia, Hairy Cell; Cladribine; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Rituximab
    Categories: Genetics; Administration & Dosage; Drug Therapy; Therapy; Pathology; Physiopathology

  19. Dasanu, Constantin A   Hematology & Oncology   Google Publications
    Lucy Curci Cancer Center, Eisenhower Medical Center/University of Southern California, Rancho Mirage, CA, USA. Top Hospital
    Medical school: Other (MD, 1994)
    Disclosed payments in 2021 from 2 biomedical companies, totalling $28.99, including $17.07 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Leukemia, Hairy Cell; Immune System Diseases; Neoplasms, Second Primary; Pentostatin; Adenocarcinoma; Antineoplastic Agents
    Categories: Chemically Induced; Adverse Effects; Complications; Drug Therapy; Immunology; Therapeutic Use

  20. Kreitman, Robert J     ClinicalTrials.gov Google Publications
    Laboratory of Molecular Biology, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Subjects: Leukemia, Hairy Cell; Bacterial Toxins; Antineoplastic Agents; Exotoxins; Cladribine; Immunoglobulin Heavy Chains
    Categories: Therapeutic Use; Genetics; Drug Therapy; Metabolism; Diagnosis; Therapy

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);